CDSCO Panel Directs Mankind Pharma to Conduct Phase I Trial of Sintilimab Before Phase III Launch
New Delhi: The Subject Expert Committee functioning under the Central Drugs Standard Control Organisation (CDSCO) has opined Mankind Pharma should first conduct a Phase I clinical trial in India for…
